| |
| |
|
| Insider
Information: |
Freyman Thomas C |
| Relationship: |
|
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
521,367 |
|
|
Indirect Shares
|
168,894 |
|
|
| Direct
Value |
$61,568,274 |
|
|
|
Indirect Value
|
$18,117,399 |
|
|
| Total
Shares |
690,261 |
|
|
| Total
Value |
$79,685,673 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
Executive Vice President |
2016-07-29 |
395,819 |
2016-07-29 |
161,012 |
Premium* |
|
|
Tenneco Automotive Inc |
TEN |
Director |
2022-11-17 |
0 |
2013-01-16 |
0 |
Premium* |
|
|
Hanger Orthopedic Group Inc |
HGR |
Director |
2022-10-03 |
0 |
2017-11-15 |
0 |
Premium* |
|
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2018-06-13 |
0 |
Premium* |
|
|
Abbvie Inc. |
ABBV |
|
2024-05-03 |
125,548 |
2024-05-03 |
7,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
168 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEN |
Tenneco Automotive Inc |
Director |
– • – |
2013-01-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
| ABBV |
Abbvie Inc. |
Director |
– • – |
2020-05-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,000 |
|
% |
|
| ABBV |
Abbvie Inc. |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
114,759 |
|
- |
|
| ABBV |
Abbvie Inc. |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
4,000 |
|
- |
|
| ABBV |
Abbvie Inc. |
Director |
– • – |
2020-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
114,759 |
|
% |
|
| ABBV |
Abbvie Inc. |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
7,882 |
|
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2007-01-03 |
4 |
S |
$49.04 |
$3,237 |
D/D |
(66) |
221,543 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2003-07-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
480 |
155,614 |
|
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2004-01-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
562 |
164,161 |
|
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2019-04-30 |
4 |
D |
$147.00 |
$109,956 |
D/D |
(748) |
1,910 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2006-02-15 |
4 |
S |
$43.85 |
$34,203 |
D/D |
(780) |
197,665 |
|
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2009-02-17 |
4 |
S |
$54.41 |
$51,909 |
D/D |
(954) |
314,075 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,056 |
294,355 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,056 |
1,197 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2018-08-30 |
4 |
B |
$190.69 |
$209,759 |
D/D |
1,100 |
2,658 |
2.39 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2009-01-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,110 |
1,567 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2010-02-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,122 |
1,941 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2010-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,122 |
336,393 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2007-01-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,137 |
236,829 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2007-01-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,137 |
845 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2006-02-18 |
4 |
D |
$44.15 |
$53,995 |
D/D |
(1,223) |
196,442 |
|
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2007-02-18 |
4 |
D |
$52.49 |
$64,195 |
D/D |
(1,223) |
270,581 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-18 |
4 |
D |
$55.55 |
$67,938 |
D/D |
(1,223) |
320,771 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
|
– • – |
2024-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,322 |
125,548 |
0 |
- |
|
| ABT |
Abbott Laboratories |
officerTitle |
• – – |
2006-01-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,398 |
466 |
|
- |
|
168 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
